You are here

home  ›  site search

Search

Researchers

Upcoming events

Research Areas

Addiction
ADDICTION
> Read More
Immunology
AUTOIMMUNE AND AUTOINFLAMMATORY DISEASES
> Read More
Trauma
BLAST TRAUMA
> Read More
Cancer
BLOOD CANCER
> Read More
Immunology
BONE AND JOINT DISEASES
Researchers at TRI are investigating bone and joint diseases including rheumatoid arthritis,...
> Read More

Promising new drug for acute myeloid leukaemia

Article
A drug currently in clinical trials has the potential to improve the survival rate of Australians diagnosed with acute myeloid leukaemia, following the outcomes of preclinical research by Mater...Read more

Melanoma revealing its secrets

Article
University of Queensland (UQ) researchers based at TRI are unlocking the secrets of melanoma cells to identify potential new drug targets and personalised treatment regimens for patients with the...Read more

New drug to beat chemo resistance in ovarian cancer

Article
Scientists from Mater Research – The University of Queensland, have discovered they can overcome chemotherapy resistance in an ovarian cancer subtype by using low doses of a drug which slows...Read more

Supercharging flu vaccine

Article
Respiratory researchers based at the Princess Alexandra Hospital and the TRI are leading a clinical trial to test a potentially simple and inexpensive solution to older people succumbing to influenza...Read more

Vaccine patch trial success

Article
Largest microarray patch clinical vaccination study ever performed Immune response significantly higher, faster Vaccine shown to be stable for 12 months at temperatures as high as 40 o C Vaxxas...Read more

Parkinson’s disease linked to gene targeted by blue-green algae toxin

Article
Scientists have discovered a possible link between Parkinson’s disease and a gene impacted by a neurotoxin found in blue-green algae. TRI-based, University of Queensland and Mater Research...Read more

SPARQ-ed is back

Article
SPARQ-ed is back in 2021! SPARQ-Ed (Students Performing Advanced Research Queensland – Education) is back - continuing its mission to deliver sustainable and accessible world-class biomedical...Read more

New Biobank improves breast cancer research

Article
Mater researchers based at TRI have partnered with QUT’s Institute of Health and Biomedical Innovation (IHBI) to establish a unique breast cancer biobank to better support Queensland...Read more

New drug combination could support better cancer treatments

Article
New drug combination could support better cancer treatments A/Prof Fiona Simpson and her Cancer Research group from UQ, based at TRI have identified a promising new drug combination that could...Read more

Melanoma risk in young Australians goes beyond the burn

Article
Australians with melanoma detected before they turn 40 are more likely to have the cancer on non-sun damaged parts of the body compared to people diagnosed when older. University of Queensland...Read more

TRI CEO calls for Eureka Award nominations

Article
TRI CEO calls for Eureka Award nominations TRI CEO Professor Scott Bell is strongly encouraging researchers based at the Institute to enter the 2020 Australian Museum Eureka Prizes. Known as the...Read more

Trial begins for new throat cancer treatment

Article
The Translational Research Institute (TRI) has awarded a research grant to fund a Phase I clinical trial for an innovative new treatment for head and neck cancer associated with Human Papillomavirus...Read more

Source of inflammation found for Rheumatoid arthritis

Article
TRI-based researchers from The University of Queensland (UQ) were involved in discovering how joint inflammation evolves in rheumatoid arthritis, and the cells that prolong the inflammatory attack...Read more

1.5 million funding for ageing and aged care research

Article
$1.5 million funding for ageing and aged care research In December 2019 the Australian Government awarded $1.5 million funding to Prof Ruth Hubbard for The GOAL Trial: Comprehensive Geriatric...Read more

Professor Ruth Hubbard Receives $1.5 million in research funding

Article
Professor Ruth Hubbard Receives $1.5 million in research funding The funding was announced as part of the Morrison Government commitment for research into aged care and better outcomes for older...Read more

New CEO for the Translational Research Institute

Article
New CEO for the Translational Research Institute The Translational Research Institute (TRI) Board has appointed renowned respiratory specialist, Professor Scott Bell as the Institute’s new CEO...Read more

Cancer chromosomes give the game away

Article
Cancer cells gain and lose so-called ‘chromosome arms’ during tumour growth, with researchers finding these changes can help predict drug response and patient survival rates as well as...Read more

Blood pressure drug could help problem drinkers

Article
A drug used to treat high blood pressure may alleviate anxiety induced by long-term heavy alcohol use, and also halt the damage such drinking can cause to the brain’s ability to grow new cells...Read more

Targeting obesity-related liver disease

Article
A new spin-out from The University of Queensland (UQ) will develop a novel therapy for the growing problem of obesity-related liver disease with the support of an initial investment from IP Group...Read more

Immune ‘checkpoint switch-off’ enables cancer cells destruction

Article
An important collaboration between researchers from the Mater Hospital, the Translational Research Institute (TRI) and the Griffith Institute for Drug Discovery (GRIDD) has led to a significant...Read more

Dr Felicity Davis wins 2019 Metcalf Prizes for Stem Cell Research

Article
Dr Felicity Davis wins 2019 Metcalf Prizes for Stem Cell Research Dr Felicity Davis of Mater Research Institute-University of Queensland is investigating the secret life of mammaries: how they...Read more

Australian Centre for Complex Integrated Surgical Solutions (ACCISS) launch

Article
Australian Centre for Complex Integrated Surgical Solutions (ACCISS) launched On Friday, 18 October we celebrated the launch of Australian Centre for Complex Integrated Surgical Solutions (ACCISS) ,...Read more

Microba to move into the US medical market

Article
Microba to move into the US medical market Five Queensland start-ups specialising in medical technology and therapeutics have touched down in San Francisco, one of the world’s life sciences hot...Read more

The Dilemmas of Governance and Translational Trials Summary

Article
The Dilemmas of Governance and Translational Trials: Summary The topic, “Dilemmas of Governance and Translational Trials”, came from questions during the second forum entitled, “To...Read more

The Hon Karen Andrews, MP officially opens MTP office in TRI building

Article
The Hon Karen Andrews MP, officially opens MTP office in TRI building TRI was delighted to co-host the Hon Karen Andrews MP, Minister for Industry, Science and Technology yesterday who was here to...Read more

Key Learnings from IMAGINE 2019

Article
KEY LEARNINGS FROM IMAGINE 2019 The two day symposium featured world leading experts from the UK, Germany, America, Italy and Australia. The event was an excellent opportunity for attendees to learn...Read more

Jyotsna Batra Awarded Young Tall Poppy Award

Article
A/Prof Jyotsna Batra wins a 2019 Queensland Young Tall Poppy Science Award Congratulations to QUT’s Associate Professor Jyotsna Batra, who has been selected as an Outstanding Early Career...Read more

UICC shortlists Professor Ian Frazer AC for its Outstanding Contribution to Cancer Control Award

Article
UICC shortlists Professor Ian Frazer AC for its Outstanding Contribution to Cancer Control Award Professor Ian Frazer AC has been nominated for the prestigious Outstanding Contribution to Cancer...Read more

Over $8 million in funding boost for TRI based researchers announced

Article
Over $8.7 million in funding boost for TRI based researchers announced The Federal Minister for Health Greg Hunt MP, announced today that over 298 new projects will receive funding from the National...Read more

Immune Infiltration & Outcomes in Lymphoma

Article
Reduced immune infiltration into nodes associated with poor outcomes in follicular lymphoma Research published today in the highly prestigious Journal of Clinical Oncology by Mater Research CEO and...Read more

Pages